Antipsychotic Drugs Market 2020 Industry Analysis by Share, Outlook, Trends and Forecast till 2026

The schizophrenia segment emerged dominant in the global antipsychotic drugs market in 2018. The segment had acquired an astonishing 45.2% of the global “antipsychotic drugs market share” in the same year owing to the rising prevalence of the disorder. This information is published in a report by Fortune Business Insights, titled, “Antipsychotic Drugs: Global Market Analysis, Insights and Forecast, 2019-2026.”

According to the report, the global market was worth US$ 14,963.5 Mn in 2018. However, Fortune Business Insights predicts that the global market will reach US$ 20,539.5 Mn by 2026, exhibiting a CAGR of 4.0% in the forecast period.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/antipsychotic-drugs-market-101390

Leading Players operating in the Antipsychotic Drugs Market are:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

• Lundbeck A/S
• Otsuka Pharmaceutical Co., Ltd.
• Janssen Pharmaceuticals, Inc.
• Eli Lilly and Company
• AstraZeneca
• ALLERGAN
• Vanda Pharmaceuticals Inc.
• Sumitomo Dainippon Pharma Co., Ltd.
• Alkermes plc
• Pfizer Inc.
• Bristol-Myers Squibb Company
• Other Prominent Players

An Overview of the Impact of COVID-19 on this Market:

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.

We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.

Click here to get the short-term and long-term impact of COVID-19 on this Antipsychotic Drugs Market. Please visit: https://www.fortunebusinessinsights.com/industry-reports/antipsychotic-drugs-market-101390

Rapid Shift Towards Advanced and Safe Drugs to Favor Growth in North America

Geographically, the global antipsychotic drugs market is grouped into Latin America, Asia Pacific, North America, the Middle East and Africa, and Europe. Amongst these regions, North America had acquired US$ 9,307.3 Mn antipsychotic drugs market revenue in the year 2018. The growth is attributed to the increasing patient pool suffering from psychotic disorders in the region. Additionally, a rapid shift of these patients towards safe antipsychotic drugs for the treatment of schizophrenia, bipolar disorder, and other psychotic diseases is expected to drive the antipsychotic drugs market in this region. Several healthcare organizations in North America have also begun promoting such drugs for treatment.

In Asia Pacific, emerging countries, such as India, China, and other Southeast Asian countries have a large patient pool who are suffering from various disorders, especially schizophrenia. Moreover, the populace residing in these countries are preferring second-generation drugs over first-generation antipsychotic drugs. It is because of the increasing healthcare expenditure and increasing awareness programs regarding the usage of these drugs. Fortune Business Insights predicts that Europe would follow the footsteps of North America and would remain in the second position throughout the forecast period. The growth is attributed to a rise in the patient population and increasing incidence of psychotic diseases.

Detailed Table of Content:

1. IntroductionResearch Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
5. Executive Summary
6. Market DynamicsMarket Drivers
7. Market Restraints
8. Market Opportunities
9. Key InsightsOverview of Prevalence of Psychiatric Disorders by Key Regions
10. Pipeline Analysis
11. Key Industry Developments
12. New Product Launches
13. Analysis of the Cost and Burden of Mental Health Disorders
14. Analysis of Antipsychotics in Treatment of Dementia
15. Analysis of First Generation Antipsychotics versus Second & Third Generation Antipsychotics
16. Overview of R&D Initiatives
17. Global Antipsychotic Drugs Market Analysis, Insights and Forecast, 2015-2026Key Findings / Summary
18. Market Analysis, Insights and Forecast – By DiseaseSchizophrenia
19. Bipolar Disorder
20. Unipolar Depression
21. Dementia
22. Others
23. Market Analysis, Insights and Forecast – By Therapeutic ClassFirst Generation
24. Second Generation
25. Third Generation
26. Market Analysis, Insights and Forecast – By Distribution ChannelHospital Pharmacies
27. Retail Pharmacies
28. Online Pharmacies
29. Others
30. Market Analysis, Insights and Forecast – By RegionNorth America
31. Europe
32. Asia Pacific
33. Latin America
34. Middle East & Africa
35. North America Antipsychotic Drugs Market Analysis, Insights and Forecast, 2015-2026Key Findings / Summary
36. Market Analysis – By DiseaseSchizophrenia
37. Bipolar Disorder
38. Unipolar Depression
39. Dementia
40. Others
41. Market Analysis – By Therapeutic ClassFirst Generation
42. Second Generation
43. Third Generation
44. Market Analysis – By Distribution ChannelHospital Pharmacies
45. Retail Pharmacies
46. Online Pharmacies
47. Others
48. Market Analysis – By CountryS.
49. Canada
50. Europe Antipsychotic Drugs Market Analysis, Insights and Forecast, 2015-2026Key Findings / Summary
51. Market Analysis – By DiseaseSchizophrenia
52. Bipolar Disorder
53. Unipolar Depression
54. Dementia
55. Others
56. Market Analysis – By Therapeutic ClassFirst Generation
57. Second Generation
58. Third Generation
59. Market Analysis – By Distribution ChannelHospital Pharmacies
60. Retail Pharmacies
61. Online Pharmacies
62. Others
63. Market Analysis – By CountryK.
64. Germany
65. France
66. Spain
67. Italy
68. Scandinavia
69. Rest of Europe
70. Asia Pacific Antipsychotic Drugs Market Analysis, Insights and Forecast, 2015-2026Key Findings / Summary
71. Market Analysis – By DiseaseSchizophrenia
72. Bipolar Disorder
73. Unipolar Depression
74. Dementia
75. Others
76. Market Analysis – By Therapeutic ClassFirst Generation
77. Second Generation
78. Third Generation
79. Market Analysis – By Distribution ChannelHospital Pharmacies
80. Retail Pharmacies
81. Online Pharmacies
82. Others
83. Market Analysis – By Country/ Sub-RegionJapan
84. China
85. India
86. Australia
87. Southeast Asia
88. Rest of Asia Pacific

Continued...

Have Any Query? Ask Our Experts:https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/antipsychotic-drugs-market-101390

Report Focus:

• Extensive product offerings
• Customer research services
• Robust research methodology
• Comprehensive reports
• Latest technological developments
• Value chain analysis
• Potential Antipsychotic Drugs Market opportunities
• Growth dynamics
• Quality assurance
• Post-sales support
• Regular report updates

Reasons to Purchase this Report:

• Comprehensive analysis of the Antipsychotic Drugs Market growth drivers, obstacles, opportunities, and other related challenges.
• Tracks the developments, such as new product launches, agreements, mergers and acquisitions, geographical expansions, and joint ventures.
• Identifies market restraints and boosters.
• Identifies all the possible segments present in the market to aid organizations in strategic business planning.

More Trending Topics From Fortune Business Insights@

Craniomaxillofacial Implants Market 2020 Global Industry Demand, Recent Trends, Size and Share Estimation by 2026 with Top Players

Fiberscope Market 2020-2026: Market Share, Applications, Growth Trends and Forecast Report

Sinuscopes Market 2020: Global Industry Overview By Size, Share, Trends, Growth Factors, Opportunities and Forecast 2026

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune - 411045, Maharashtra, India.

Phone:

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email:sales@fortunebusinessinsights.com

Linkedin | Twitter | BLogs